
### [MONDO:0002661](http://purl.obolibrary.org/obo/MONDO_0002661)
**Label:** uveal disease

**Subclasses:** [MONDO:0017259](http://purl.obolibrary.org/obo/MONDO_0017259) (systemic diseases with anterior uveitis), [MONDO:0017258](http://purl.obolibrary.org/obo/MONDO_0017258) (idiopathic panuveitis), [MONDO:0019437](http://purl.obolibrary.org/obo/MONDO_0019437) (Enthesitis-related juvenile idiopathic arthritis), [MONDO:0017255](http://purl.obolibrary.org/obo/MONDO_0017255) (panuveitis (disease)), [MONDO:0015198](http://purl.obolibrary.org/obo/MONDO_0015198) (aniridia-ptosis-intellectual disability-familial obesity syndrome), [MONDO:0003927](http://purl.obolibrary.org/obo/MONDO_0003927) (posterior uveal melanoma), [MONDO:0019432](http://purl.obolibrary.org/obo/MONDO_0019432) (rheumatoid factor-negative juvenile idiopathic arthritis), [MONDO:0017257](http://purl.obolibrary.org/obo/MONDO_0017257) (idiopathic posterior uveitis), [MONDO:0015199](http://purl.obolibrary.org/obo/MONDO_0015199) (aniridia-intellectual disability syndrome), [MONDO:0017256](http://purl.obolibrary.org/obo/MONDO_0017256) (idiopathic anterior uveitis), [MONDO:0019433](http://purl.obolibrary.org/obo/MONDO_0019433) (Oligoarticular juvenile idiopathic arthritis), [MONDO:0006918](http://purl.obolibrary.org/obo/MONDO_0006918) (posterior uveitis), [MONDO:0020148](http://purl.obolibrary.org/obo/MONDO_0020148) (syndromic aniridia), [MONDO:0001986](http://purl.obolibrary.org/obo/MONDO_0001986) (Argyll Robertson pupil), [MONDO:0007966](http://purl.obolibrary.org/obo/MONDO_0007966) (susceptibility to uveal melanoma), [MONDO:0000013](http://purl.obolibrary.org/obo/MONDO_0000013) (choroidal dystrophy), [MONDO:0007684](http://purl.obolibrary.org/obo/MONDO_0007684) (granulomatous disease, chronic, autosomal dominant type), [MONDO:0006990](http://purl.obolibrary.org/obo/MONDO_0006990) (suppurative uveitis), [MONDO:0016207](http://purl.obolibrary.org/obo/MONDO_0016207) (phacoanaphylactic uveitis), [MONDO:0016206](http://purl.obolibrary.org/obo/MONDO_0016206) (idiopathic uveal effusion syndrome), [MONDO:0012889](http://purl.obolibrary.org/obo/MONDO_0012889) (SS3), [MONDO:0012888](http://purl.obolibrary.org/obo/MONDO_0012888) (sarcoidosis, susceptibility to, 2), [MONDO:0019541](http://purl.obolibrary.org/obo/MONDO_0019541) (non-infectious posterior uveitis), [MONDO:0002969](http://purl.obolibrary.org/obo/MONDO_0002969) (ciliary body cancer), [MONDO:0021225](http://purl.obolibrary.org/obo/MONDO_0021225) (uvea neoplasm), [MONDO:0006806](http://purl.obolibrary.org/obo/MONDO_0006806) (intermediate uveitis (disease)), [MONDO:0021224](http://purl.obolibrary.org/obo/MONDO_0021224) (iris neoplasm), [MONDO:0009624](http://purl.obolibrary.org/obo/MONDO_0009624) (microcephaly and chorioretinopathy 1), [MONDO:0021229](http://purl.obolibrary.org/obo/MONDO_0021229) (ciliary body neoplasm), [MONDO:0002289](http://purl.obolibrary.org/obo/MONDO_0002289) (iris disease), [MONDO:0006885](http://purl.obolibrary.org/obo/MONDO_0006885) (panuveitis), [MONDO:0004188](http://purl.obolibrary.org/obo/MONDO_0004188) (iris spindle cell melanoma), [MONDO:0014938](http://purl.obolibrary.org/obo/MONDO_0014938) (aniridia 3; AN3), [MONDO:0006486](http://purl.obolibrary.org/obo/MONDO_0006486) (uveal melanoma), [MONDO:0004065](http://purl.obolibrary.org/obo/MONDO_0004065) (intermediate cell type choroid melanoma), [MONDO:0002164](http://purl.obolibrary.org/obo/MONDO_0002164) (focal chorioretinitis), [MONDO:0004066](http://purl.obolibrary.org/obo/MONDO_0004066) (intermediate cell type ciliary body melanoma), [MONDO:0002285](http://purl.obolibrary.org/obo/MONDO_0002285) (pupil disease), [MONDO:0004063](http://purl.obolibrary.org/obo/MONDO_0004063) (intermediate cell type iris melanoma), [MONDO:0004064](http://purl.obolibrary.org/obo/MONDO_0004064) (iris melanoma), [MONDO:0014937](http://purl.obolibrary.org/obo/MONDO_0014937) (aniridia 2; AN2), [MONDO:0004062](http://purl.obolibrary.org/obo/MONDO_0004062) (intermediate cell type uveal melanoma), [MONDO:0012913](http://purl.obolibrary.org/obo/MONDO_0012913) (wilms tumor, aniridia, genitourinary anomalies, mental retardation, and obesity syndrome), [MONDO:0017634](http://purl.obolibrary.org/obo/MONDO_0017634) (non-infectious anterior uveitis), [MONDO:0013151](http://purl.obolibrary.org/obo/MONDO_0013151) (CACD3), [MONDO:0002659](http://purl.obolibrary.org/obo/MONDO_0002659) (uveal cancer), [MONDO:0002658](http://purl.obolibrary.org/obo/MONDO_0002658) (iris cancer), [MONDO:0008523](http://purl.obolibrary.org/obo/MONDO_0008523) (Blau syndrome), [MONDO:0003745](http://purl.obolibrary.org/obo/MONDO_0003745) (choroid spindle cell melanoma), [MONDO:0003746](http://purl.obolibrary.org/obo/MONDO_0003746) (ciliary body spindle cell melanoma), [MONDO:0006611](http://purl.obolibrary.org/obo/MONDO_0006611) (skin sarcoidosis), [MONDO:0004674](http://purl.obolibrary.org/obo/MONDO_0004674) (chorioretinitis (disease)), [MONDO:0011776](http://purl.obolibrary.org/obo/MONDO_0011776) (CINCA syndrome), [MONDO:0001280](http://purl.obolibrary.org/obo/MONDO_0001280) (choroiditis), [MONDO:0010600](http://purl.obolibrary.org/obo/MONDO_0010600) (granulomatous disease, chronic, X-linked), [MONDO:0014592](http://purl.obolibrary.org/obo/MONDO_0014592) (microcephaly and chorioretinopathy 3), [MONDO:0003912](http://purl.obolibrary.org/obo/MONDO_0003912) (malignant ciliary body melanoma), [MONDO:0018152](http://purl.obolibrary.org/obo/MONDO_0018152) (serpiginous choroiditis), [MONDO:0003913](http://purl.obolibrary.org/obo/MONDO_0003913) (choroid mixed cell melanoma), [MONDO:0003910](http://purl.obolibrary.org/obo/MONDO_0003910) (mixed cell uveal melanoma), [MONDO:0003878](http://purl.obolibrary.org/obo/MONDO_0003878) (malignant choroid melanoma), [MONDO:0003911](http://purl.obolibrary.org/obo/MONDO_0003911) (ciliary body mixed cell melanoma), [MONDO:0001211](http://purl.obolibrary.org/obo/MONDO_0001211) (total internal ophthalmoplegia), [MONDO:0011644](http://purl.obolibrary.org/obo/MONDO_0011644) (pars planitis), [MONDO:0014516](http://purl.obolibrary.org/obo/MONDO_0014516) (microcephaly and chorioretinopathy 2), [MONDO:0011885](http://purl.obolibrary.org/obo/MONDO_0011885) (tubulointerstitial nephritis and uveitis syndrome), [MONDO:0010557](http://purl.obolibrary.org/obo/MONDO_0010557) (choroideremia), [MONDO:0018305](http://purl.obolibrary.org/obo/MONDO_0018305) (chronic granulomatous disease), [MONDO:0001709](http://purl.obolibrary.org/obo/MONDO_0001709) (hypercalcemic sarcoidosis), [MONDO:0017211](http://purl.obolibrary.org/obo/MONDO_0017211) (infectious panuveitis), [MONDO:0001706](http://purl.obolibrary.org/obo/MONDO_0001706) (cerebral sarcoidosis), [MONDO:0017210](http://purl.obolibrary.org/obo/MONDO_0017210) (infectious anterior uveitis), [MONDO:0001708](http://purl.obolibrary.org/obo/MONDO_0001708) (pulmonary sarcoidosis), [MONDO:0009310](http://purl.obolibrary.org/obo/MONDO_0009310) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2), [MONDO:0017212](http://purl.obolibrary.org/obo/MONDO_0017212) (paraneoplastic uveitis), [MONDO:0001707](http://purl.obolibrary.org/obo/MONDO_0001707) (cardiac sarcoidosis), [MONDO:0008982](http://purl.obolibrary.org/obo/MONDO_0008982) (central areolar choroidal dystrophy), [MONDO:0009796](http://purl.obolibrary.org/obo/MONDO_0009796) (gyrate atrophy), [MONDO:0019198](http://purl.obolibrary.org/obo/MONDO_0019198) (sympathetic ophthalmia), [MONDO:0012281](http://purl.obolibrary.org/obo/MONDO_0012281) (sarcoidosis, early-onset), [MONDO:0004898](http://purl.obolibrary.org/obo/MONDO_0004898) (total circumpapillary dystrophy of choroid), [MONDO:0001303](http://purl.obolibrary.org/obo/MONDO_0001303) (abnormal pupillary function (disease)), [MONDO:0004657](http://purl.obolibrary.org/obo/MONDO_0004657) (disseminated chorioretinitis), [MONDO:0001424](http://purl.obolibrary.org/obo/MONDO_0001424) (sarcoid meningitis), [MONDO:0004775](http://purl.obolibrary.org/obo/MONDO_0004775) (lens-induced iridocyclitis), [MONDO:0004773](http://purl.obolibrary.org/obo/MONDO_0004773) (iridocyclitis (disease)), [MONDO:0004774](http://purl.obolibrary.org/obo/MONDO_0004774) (gonococcal iridocyclitis), [MONDO:0004772](http://purl.obolibrary.org/obo/MONDO_0004772) (glaucomatocyclitic crisis), [MONDO:0021273](http://purl.obolibrary.org/obo/MONDO_0021273) (leiomyoma of ciliary body), [MONDO:0004890](http://purl.obolibrary.org/obo/MONDO_0004890) (partial central choroid dystrophy), [MONDO:0011599](http://purl.obolibrary.org/obo/MONDO_0011599) (birdshot chorioretinopathy), [MONDO:0007120](http://purl.obolibrary.org/obo/MONDO_0007120) (aniridia-absent patella syndrome), [MONDO:0013137](http://purl.obolibrary.org/obo/MONDO_0013137) (choroidal dystrophy, central areolar 2), [MONDO:0021542](http://purl.obolibrary.org/obo/MONDO_0021542) (hemangioma of choroid), [MONDO:0009307](http://purl.obolibrary.org/obo/MONDO_0009307) (granulomatous disease with defect 1N neutrophil chemotaxis), [MONDO:0009308](http://purl.obolibrary.org/obo/MONDO_0009308) (granulomatous disease, chronic, autosomal recessive, cytochrome b-negative), [MONDO:0009309](http://purl.obolibrary.org/obo/MONDO_0009309) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1), [MONDO:0001036](http://purl.obolibrary.org/obo/MONDO_0001036) (hypopyon), [MONDO:0001035](http://purl.obolibrary.org/obo/MONDO_0001035) (hypopyon ulcer), [MONDO:0001393](http://purl.obolibrary.org/obo/MONDO_0001393) (peripheral focal chorioretinitis), [MONDO:0006200](http://purl.obolibrary.org/obo/MONDO_0006200) (epithelioid cell uveal melanoma), [MONDO:0007011](http://purl.obolibrary.org/obo/MONDO_0007011) (uveoparotid fever), [MONDO:0000181](http://purl.obolibrary.org/obo/MONDO_0000181) (microcephaly and chorioretinopathy), [MONDO:0017209](http://purl.obolibrary.org/obo/MONDO_0017209) (infectious posterior uveitis), [MONDO:0007191](http://purl.obolibrary.org/obo/MONDO_0007191) (Behcet's syndrome), [MONDO:0019338](http://purl.obolibrary.org/obo/MONDO_0019338) (sarcoidosis), [MONDO:0008681](http://purl.obolibrary.org/obo/MONDO_0008681) (WAGR syndrome), [MONDO:0011695](http://purl.obolibrary.org/obo/MONDO_0011695) (melanoma, uveal, susceptibility to, 1), [MONDO:0021258](http://purl.obolibrary.org/obo/MONDO_0021258) (choroid neoplasm), [MONDO:0008327](http://purl.obolibrary.org/obo/MONDO_0008327) (exfoliation syndrome), [MONDO:0004879](http://purl.obolibrary.org/obo/MONDO_0004879) (senile atrophy of choroid), [MONDO:0006814](http://purl.obolibrary.org/obo/MONDO_0006814) (iritis (disease)), [MONDO:0019172](http://purl.obolibrary.org/obo/MONDO_0019172) (aniridia), [MONDO:0002970](http://purl.obolibrary.org/obo/MONDO_0002970) (ciliary body disease), [MONDO:0018092](http://purl.obolibrary.org/obo/MONDO_0018092) (Vogt-Koyanagi-Harada disease), [MONDO:0020283](http://purl.obolibrary.org/obo/MONDO_0020283) (uveitis (disease)), [MONDO:0006651](http://purl.obolibrary.org/obo/MONDO_0006651) (anterior uveitis (disease)), [MONDO:0011696](http://purl.obolibrary.org/obo/MONDO_0011696) (melanoma, uveal, susceptibility to, 2), [MONDO:0016989](http://purl.obolibrary.org/obo/MONDO_0016989) (Fuchs heterochromic iridocyclitis), [MONDO:0021487](http://purl.obolibrary.org/obo/MONDO_0021487) (benign neoplasm of choroid), [MONDO:0008399](http://purl.obolibrary.org/obo/MONDO_0008399) (sarcoidosis, susceptibility to, 1), [MONDO:0008795](http://purl.obolibrary.org/obo/MONDO_0008795) (aniridia-cerebellar ataxia-intellectual disability syndrome), [MONDO:0021486](http://purl.obolibrary.org/obo/MONDO_0021486) (benign neoplasm of ciliary body), [MONDO:0008796](http://purl.obolibrary.org/obo/MONDO_0008796) (aniridia-renal agenesis-psychomotor retardation syndrome), [MONDO:0017261](http://purl.obolibrary.org/obo/MONDO_0017261) (systemic diseases with panuveitis), [MONDO:0004889](http://purl.obolibrary.org/obo/MONDO_0004889) (central gyrate choroidal dystrophy), [MONDO:0001898](http://purl.obolibrary.org/obo/MONDO_0001898) (choroid disease), [MONDO:0017260](http://purl.obolibrary.org/obo/MONDO_0017260) (systemic diseases with posterior uveitis), [MONDO:0004888](http://purl.obolibrary.org/obo/MONDO_0004888) (partial circumpapillary choroid dystrophy), [MONDO:0007119](http://purl.obolibrary.org/obo/MONDO_0007119) (isolated aniridia), [MONDO:0004885](http://purl.obolibrary.org/obo/MONDO_0004885) (choroidal sclerosis), [MONDO:0004886](http://purl.obolibrary.org/obo/MONDO_0004886) (diffuse secondary choroid atrophy), [MONDO:0006700](http://purl.obolibrary.org/obo/MONDO_0006700) (choroid cancer), [MONDO:0004883](http://purl.obolibrary.org/obo/MONDO_0004883) (hereditary choroidal atrophy), [MONDO:0004364](http://purl.obolibrary.org/obo/MONDO_0004364) (choroid necrotic melanoma), [MONDO:0004882](http://purl.obolibrary.org/obo/MONDO_0004882) (angioid streaks of choroid), [MONDO:0004365](http://purl.obolibrary.org/obo/MONDO_0004365) (necrotic uveal melanoma), [MONDO:0021485](http://purl.obolibrary.org/obo/MONDO_0021485) (benign neoplasm of iris), [MONDO:0004085](http://purl.obolibrary.org/obo/MONDO_0004085) (choroid epithelioid cell melanoma), [MONDO:0016618](http://purl.obolibrary.org/obo/MONDO_0016618) (rheumatoid factor-negative juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0004086](http://purl.obolibrary.org/obo/MONDO_0004086) (ciliary body epithelioid cell melanoma), [MONDO:0016617](http://purl.obolibrary.org/obo/MONDO_0016617) (rheumatoid factor-negative juvenile idiopathic arthritis with anti-nuclear antibodies), [MONDO:0013507](http://purl.obolibrary.org/obo/MONDO_0013507) (granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 3), [MONDO:0016616](http://purl.obolibrary.org/obo/MONDO_0016616) (Oligoarticular juvenile idiopathic arthritis without anti-nuclear antibodies), [MONDO:0016615](http://purl.obolibrary.org/obo/MONDO_0016615) (Oligoarticular juvenile idiopathic arthritis with anti-nuclear antibodies), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum), [GO:0000979](http://purl.obolibrary.org/obo/GO_0000979) (RNA polymerase II core promoter sequence-specific DNA binding), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0009791](http://purl.obolibrary.org/obo/GO_0009791) (post-embryonic development), [GO:0003690](http://purl.obolibrary.org/obo/GO_0003690) (double-stranded DNA binding), [GO:0021798](http://purl.obolibrary.org/obo/GO_0021798) (forebrain dorsal/ventral pattern formation), [GO:0004663](http://purl.obolibrary.org/obo/GO_0004663) (Rab geranylgeranyltransferase activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0021796](http://purl.obolibrary.org/obo/GO_0021796) (cerebral cortex regionalization), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0005507](http://purl.obolibrary.org/obo/GO_0005507) (copper ion binding), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0048246](http://purl.obolibrary.org/obo/GO_0048246) (macrophage chemotaxis), [GO:0045893](http://purl.obolibrary.org/obo/GO_0045893) (positive regulation of transcription, DNA-templated), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0001709](http://purl.obolibrary.org/obo/GO_0001709) (cell fate determination), [GO:0019901](http://purl.obolibrary.org/obo/GO_0019901) (protein kinase binding), [GO:0035035](http://purl.obolibrary.org/obo/GO_0035035) (histone acetyltransferase binding), [GO:0090104](http://purl.obolibrary.org/obo/GO_0090104) (pancreatic epsilon cell differentiation), [GO:0019903](http://purl.obolibrary.org/obo/GO_0019903) (protein phosphatase binding), [GO:0007264](http://purl.obolibrary.org/obo/GO_0007264) (small GTPase mediated signal transduction), [GO:0005086](http://purl.obolibrary.org/obo/GO_0005086) (ARF guanyl-nucleotide exchange factor activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0002374](http://purl.obolibrary.org/obo/GO_0002374) (cytokine secretion involved in immune response), [GO:0004674](http://purl.obolibrary.org/obo/GO_0004674) (protein serine/threonine kinase activity), [GO:0046627](http://purl.obolibrary.org/obo/GO_0046627) (negative regulation of insulin receptor signaling pathway), [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005765](http://purl.obolibrary.org/obo/GO_0005765) (lysosomal membrane), [GO:0000981](http://purl.obolibrary.org/obo/GO_0000981) (RNA polymerase II transcription factor activity, sequence-specific DNA binding), [GO:0021543](http://purl.obolibrary.org/obo/GO_0021543) (pallium development), [GO:0005635](http://purl.obolibrary.org/obo/GO_0005635) (nuclear envelope), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031902](http://purl.obolibrary.org/obo/GO_0031902) (late endosome membrane), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0016641](http://purl.obolibrary.org/obo/GO_0016641) (oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor), [GO:0071800](http://purl.obolibrary.org/obo/GO_0071800) (podosome assembly), [GO:0071837](http://purl.obolibrary.org/obo/GO_0071837) (HMG box domain binding), [GO:0021538](http://purl.obolibrary.org/obo/GO_0021538) (epithalamus development), [GO:0061351](http://purl.obolibrary.org/obo/GO_0061351) (neural precursor cell proliferation), [GO:0060021](http://purl.obolibrary.org/obo/GO_0060021) (palate development), [GO:0044212](http://purl.obolibrary.org/obo/GO_0044212) (transcription regulatory region DNA binding), [GO:0045665](http://purl.obolibrary.org/obo/GO_0045665) (negative regulation of neuron differentiation), [GO:0021778](http://purl.obolibrary.org/obo/GO_0021778) (oligodendrocyte cell fate specification), [GO:0045664](http://purl.obolibrary.org/obo/GO_0045664) (regulation of neuron differentiation), [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus), [GO:0003310](http://purl.obolibrary.org/obo/GO_0003310) (pancreatic A cell differentiation), [GO:0021772](http://purl.obolibrary.org/obo/GO_0021772) (olfactory bulb development), [GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function), [GO:0003311](http://purl.obolibrary.org/obo/GO_0003311) (pancreatic D cell differentiation), [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome), [GO:0016192](http://purl.obolibrary.org/obo/GO_0016192) (vesicle-mediated transport), [GO:0005968](http://purl.obolibrary.org/obo/GO_0005968) (Rab-protein geranylgeranyltransferase complex), [GO:0060707](http://purl.obolibrary.org/obo/GO_0060707) (trophoblast giant cell differentiation), [GO:0043010](http://purl.obolibrary.org/obo/GO_0043010) (camera-type eye development), [GO:0003309](http://purl.obolibrary.org/obo/GO_0003309) (type B pancreatic cell differentiation), [GO:0006816](http://purl.obolibrary.org/obo/GO_0006816) (calcium ion transport), [GO:2001224](http://purl.obolibrary.org/obo/GO_2001224) (positive regulation of neuron migration), [GO:0048708](http://purl.obolibrary.org/obo/GO_0048708) (astrocyte differentiation), [GO:1900042](http://purl.obolibrary.org/obo/GO_1900042) (positive regulation of interleukin-2 secretion), [GO:0003680](http://purl.obolibrary.org/obo/GO_0003680) (AT DNA binding), [GO:0009786](http://purl.obolibrary.org/obo/GO_0009786) (regulation of asymmetric cell division), [GO:0042045](http://purl.obolibrary.org/obo/GO_0042045) (epithelial fluid transport), [GO:0003682](http://purl.obolibrary.org/obo/GO_0003682) (chromatin binding), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0003322](http://purl.obolibrary.org/obo/GO_0003322) (pancreatic A cell development), [GO:0048703](http://purl.obolibrary.org/obo/GO_0048703) (embryonic viscerocranium morphogenesis), [GO:0003676](http://purl.obolibrary.org/obo/GO_0003676) (nucleic acid binding), [GO:0004402](http://purl.obolibrary.org/obo/GO_0004402) (histone acetyltransferase activity), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0005856](http://purl.obolibrary.org/obo/GO_0005856) (cytoskeleton), [GO:0043020](http://purl.obolibrary.org/obo/GO_0043020) (NADPH oxidase complex), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:1990798](http://purl.obolibrary.org/obo/GO_1990798) (pancreas regeneration), [GO:0001933](http://purl.obolibrary.org/obo/GO_0001933) (negative regulation of protein phosphorylation), [GO:0072112](http://purl.obolibrary.org/obo/GO_0072112) (glomerular visceral epithelial cell differentiation), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0098727](http://purl.obolibrary.org/obo/GO_0098727) (maintenance of cell number), [GO:0055114](http://purl.obolibrary.org/obo/GO_0055114) (oxidation-reduction process), [GO:0070059](http://purl.obolibrary.org/obo/GO_0070059) (intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0021918](http://purl.obolibrary.org/obo/GO_0021918) (regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment), [GO:0021912](http://purl.obolibrary.org/obo/GO_0021912) (regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification), [GO:0008022](http://purl.obolibrary.org/obo/GO_0008022) (protein C-terminus binding), [GO:0021913](http://purl.obolibrary.org/obo/GO_0021913) (regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification), [GO:0048798](http://purl.obolibrary.org/obo/GO_0048798) (swim bladder inflation), [GO:0006886](http://purl.obolibrary.org/obo/GO_0006886) (intracellular protein transport), [GO:1904937](http://purl.obolibrary.org/obo/GO_1904937) (sensory neuron migration), [GO:0004587](http://purl.obolibrary.org/obo/GO_0004587) (ornithine-oxo-acid transaminase activity), [GO:0001750](http://purl.obolibrary.org/obo/GO_0001750) (photoreceptor outer segment), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0002830](http://purl.obolibrary.org/obo/GO_0002830) (positive regulation of type 2 immune response), [GO:0001741](http://purl.obolibrary.org/obo/GO_0001741) (XY body), [GO:0005667](http://purl.obolibrary.org/obo/GO_0005667) (transcription factor complex), [GO:0001077](http://purl.obolibrary.org/obo/GO_0001077) (transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0032808](http://purl.obolibrary.org/obo/GO_0032808) (lacrimal gland development), [GO:0051607](http://purl.obolibrary.org/obo/GO_0051607) (defense response to virus), [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process), [GO:0021905](http://purl.obolibrary.org/obo/GO_0021905) (forebrain-midbrain boundary formation), [GO:0008270](http://purl.obolibrary.org/obo/GO_0008270) (zinc ion binding), [GO:0021902](http://purl.obolibrary.org/obo/GO_0021902) (commitment of neuronal cell to specific neuron type in forebrain), [GO:0042462](http://purl.obolibrary.org/obo/GO_0042462) (eye photoreceptor cell development), [GO:0002052](http://purl.obolibrary.org/obo/GO_0002052) (positive regulation of neuroblast proliferation), [GO:0042102](http://purl.obolibrary.org/obo/GO_0042102) (positive regulation of T cell proliferation), [GO:0045730](http://purl.obolibrary.org/obo/GO_0045730) (respiratory burst), [GO:0097060](http://purl.obolibrary.org/obo/GO_0097060) (synaptic membrane), [GO:0042347](http://purl.obolibrary.org/obo/GO_0042347) (negative regulation of NF-kappaB import into nucleus), [GO:0006527](http://purl.obolibrary.org/obo/GO_0006527) (arginine catabolic process), [GO:0021593](http://purl.obolibrary.org/obo/GO_0021593) (rhombomere morphogenesis), [GO:0000790](http://purl.obolibrary.org/obo/GO_0000790) (nuclear chromatin), [GO:0050882](http://purl.obolibrary.org/obo/GO_0050882) (voluntary musculoskeletal movement), [GO:0001755](http://purl.obolibrary.org/obo/GO_0001755) (neural crest cell migration), [GO:0030858](http://purl.obolibrary.org/obo/GO_0030858) (positive regulation of epithelial cell differentiation), [GO:0042593](http://purl.obolibrary.org/obo/GO_0042593) (glucose homeostasis), [GO:0071320](http://purl.obolibrary.org/obo/GO_0071320) (cellular response to cAMP), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0050767](http://purl.obolibrary.org/obo/GO_0050767) (regulation of neurogenesis), [GO:1905590](http://purl.obolibrary.org/obo/GO_1905590) (fibronectin fibril organization), [GO:0006182](http://purl.obolibrary.org/obo/GO_0006182) (cGMP biosynthetic process), [GO:0060221](http://purl.obolibrary.org/obo/GO_0060221) (retinal rod cell differentiation), [GO:0030170](http://purl.obolibrary.org/obo/GO_0030170) (pyridoxal phosphate binding), [GO:0005092](http://purl.obolibrary.org/obo/GO_0005092) (GDP-dissociation inhibitor activity), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0008483](http://purl.obolibrary.org/obo/GO_0008483) (transaminase activity), [GO:0005096](http://purl.obolibrary.org/obo/GO_0005096) (GTPase activator activity), [GO:0043565](http://purl.obolibrary.org/obo/GO_0043565) (sequence-specific DNA binding), [GO:0007155](http://purl.obolibrary.org/obo/GO_0007155) (cell adhesion), [GO:0000993](http://purl.obolibrary.org/obo/GO_0000993) (RNA polymerase II core binding), [GO:0005654](http://purl.obolibrary.org/obo/GO_0005654) (nucleoplasm), [GO:0005525](http://purl.obolibrary.org/obo/GO_0005525) (GTP binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0098598](http://purl.obolibrary.org/obo/GO_0098598) (learned vocalization behavior or vocal learning), [GO:0001968](http://purl.obolibrary.org/obo/GO_0001968) (fibronectin binding), [GO:0018057](http://purl.obolibrary.org/obo/GO_0018057) (peptidyl-lysine oxidation), [GO:2000178](http://purl.obolibrary.org/obo/GO_2000178) (negative regulation of neural precursor cell proliferation), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0031012](http://purl.obolibrary.org/obo/GO_0031012) (extracellular matrix), [GO:0032469](http://purl.obolibrary.org/obo/GO_0032469) (endoplasmic reticulum calcium ion homeostasis), [GO:0031018](http://purl.obolibrary.org/obo/GO_0031018) (endocrine pancreas development), [GO:0050896](http://purl.obolibrary.org/obo/GO_0050896) (response to stimulus), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0046601](http://purl.obolibrary.org/obo/GO_0046601) (positive regulation of centriole replication), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045630](http://purl.obolibrary.org/obo/GO_0045630) (positive regulation of T-helper 2 cell differentiation), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:1901215](http://purl.obolibrary.org/obo/GO_1901215) (negative regulation of neuron death), [GO:0008134](http://purl.obolibrary.org/obo/GO_0008134) (transcription factor binding), [GO:0048589](http://purl.obolibrary.org/obo/GO_0048589) (developmental growth), [GO:0044546](http://purl.obolibrary.org/obo/GO_0044546) (NLRP3 inflammasome complex assembly), [GO:0007601](http://purl.obolibrary.org/obo/GO_0007601) (visual perception), [GO:0061303](http://purl.obolibrary.org/obo/GO_0061303) (cornea development in camera-type eye), [GO:0003002](http://purl.obolibrary.org/obo/GO_0003002) (regionalization), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0071222](http://purl.obolibrary.org/obo/GO_0071222) (cellular response to lipopolysaccharide), [GO:0042491](http://purl.obolibrary.org/obo/GO_0042491) (inner ear auditory receptor cell differentiation), [GO:0097038](http://purl.obolibrary.org/obo/GO_0097038) (perinuclear endoplasmic reticulum), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0035845](http://purl.obolibrary.org/obo/GO_0035845) (photoreceptor cell outer segment organization), [GO:0071224](http://purl.obolibrary.org/obo/GO_0071224) (cellular response to peptidoglycan), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), [GO:0072559](http://purl.obolibrary.org/obo/GO_0072559) (NLRP3 inflammasome complex), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0015278](http://purl.obolibrary.org/obo/GO_0015278) (calcium-release channel activity), [GO:0007099](http://purl.obolibrary.org/obo/GO_0007099) (centriole replication), [GO:0061053](http://purl.obolibrary.org/obo/GO_0061053) (somite development), [GO:0050718](http://purl.obolibrary.org/obo/GO_0050718) (positive regulation of interleukin-1 beta secretion), [GO:0051928](http://purl.obolibrary.org/obo/GO_0051928) (positive regulation of calcium ion transport), [GO:0009952](http://purl.obolibrary.org/obo/GO_0009952) (anterior/posterior pattern specification), [GO:0004383](http://purl.obolibrary.org/obo/GO_0004383) (guanylate cyclase activity), [GO:0007411](http://purl.obolibrary.org/obo/GO_0007411) (axon guidance), [GO:0009950](http://purl.obolibrary.org/obo/GO_0009950) (dorsal/ventral axis specification), [GO:0002088](http://purl.obolibrary.org/obo/GO_0002088) (lens development in camera-type eye), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:0009953](http://purl.obolibrary.org/obo/GO_0009953) (dorsal/ventral pattern formation), [GO:0030667](http://purl.obolibrary.org/obo/GO_0030667) (secretory granule membrane), [GO:0030425](http://purl.obolibrary.org/obo/GO_0030425) (dendrite), [GO:0001666](http://purl.obolibrary.org/obo/GO_0001666) (response to hypoxia), [GO:0016491](http://purl.obolibrary.org/obo/GO_0016491) (oxidoreductase activity), [GO:0007409](http://purl.obolibrary.org/obo/GO_0007409) (axonogenesis), [GO:0019882](http://purl.obolibrary.org/obo/GO_0019882) (antigen processing and presentation), [GO:0050713](http://purl.obolibrary.org/obo/GO_0050713) (negative regulation of interleukin-1 beta secretion), [GO:0008180](http://purl.obolibrary.org/obo/GO_0008180) (COP9 signalosome), [GO:0050832](http://purl.obolibrary.org/obo/GO_0050832) (defense response to fungus), [GO:2001046](http://purl.obolibrary.org/obo/GO_2001046) (positive regulation of integrin-mediated signaling pathway), [GO:0019886](http://purl.obolibrary.org/obo/GO_0019886) (antigen processing and presentation of exogenous peptide antigen via MHC class II), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0035556](http://purl.obolibrary.org/obo/GO_0035556) (intracellular signal transduction), [GO:0008074](http://purl.obolibrary.org/obo/GO_0008074) (guanylate cyclase complex, soluble), [GO:0050728](http://purl.obolibrary.org/obo/GO_0050728) (negative regulation of inflammatory response), [GO:0034341](http://purl.obolibrary.org/obo/GO_0034341) (response to interferon-gamma), [GO:0050849](http://purl.obolibrary.org/obo/GO_0050849) (negative regulation of calcium-mediated signaling), [GO:0042660](http://purl.obolibrary.org/obo/GO_0042660) (positive regulation of cell fate specification), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0032835](http://purl.obolibrary.org/obo/GO_0032835) (glomerulus development), [GO:0031625](http://purl.obolibrary.org/obo/GO_0031625) (ubiquitin protein ligase binding), [GO:0051011](http://purl.obolibrary.org/obo/GO_0051011) (microtubule minus-end binding), [GO:0042670](http://purl.obolibrary.org/obo/GO_0042670) (retinal cone cell differentiation), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0034214](http://purl.obolibrary.org/obo/GO_0034214) (protein hexamerization), [GO:0033365](http://purl.obolibrary.org/obo/GO_0033365) (protein localization to organelle), [GO:0010942](http://purl.obolibrary.org/obo/GO_0010942) (positive regulation of cell death), [GO:0070679](http://purl.obolibrary.org/obo/GO_0070679) (inositol 1,4,5 trisphosphate binding), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0002064](http://purl.obolibrary.org/obo/GO_0002064) (epithelial cell development), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0045944](http://purl.obolibrary.org/obo/GO_0045944) (positive regulation of transcription by RNA polymerase II), [GO:0042554](http://purl.obolibrary.org/obo/GO_0042554) (superoxide anion generation), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:1990266](http://purl.obolibrary.org/obo/GO_1990266) (neutrophil migration), [GO:0001764](http://purl.obolibrary.org/obo/GO_0001764) (neuron migration), [GO:0003700](http://purl.obolibrary.org/obo/GO_0003700) (DNA binding transcription factor activity), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0070588](http://purl.obolibrary.org/obo/GO_0070588) (calcium ion transmembrane transport), [GO:0055085](http://purl.obolibrary.org/obo/GO_0055085) (transmembrane transport), [GO:0120008](http://purl.obolibrary.org/obo/GO_0120008) (positive regulation of glutamatergic neuron differentiation), [GO:0035091](http://purl.obolibrary.org/obo/GO_0035091) (phosphatidylinositol binding), [GO:0005220](http://purl.obolibrary.org/obo/GO_0005220) (inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0020037](http://purl.obolibrary.org/obo/GO_0020037) (heme binding), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0001895](http://purl.obolibrary.org/obo/GO_0001895) (retina homeostasis), [GO:0005216](http://purl.obolibrary.org/obo/GO_0005216) (ion channel activity), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0050860](http://purl.obolibrary.org/obo/GO_0050860) (negative regulation of T cell receptor signaling pathway), [GO:1990830](http://purl.obolibrary.org/obo/GO_1990830) (cellular response to leukemia inhibitory factor), [GO:0001778](http://purl.obolibrary.org/obo/GO_0001778) (plasma membrane repair), [GO:0002504](http://purl.obolibrary.org/obo/GO_0002504) (antigen processing and presentation of peptide or polysaccharide antigen via MHC class II), [GO:0045165](http://purl.obolibrary.org/obo/GO_0045165) (cell fate commitment), [GO:0061072](http://purl.obolibrary.org/obo/GO_0061072) (iris morphogenesis), [GO:0019855](http://purl.obolibrary.org/obo/GO_0019855) (calcium channel inhibitor activity), [GO:0042613](http://purl.obolibrary.org/obo/GO_0042613) (MHC class II protein complex), [GO:0060041](http://purl.obolibrary.org/obo/GO_0060041) (retina development in camera-type eye), [GO:1901142](http://purl.obolibrary.org/obo/GO_1901142) (insulin metabolic process), [GO:0060042](http://purl.obolibrary.org/obo/GO_0060042) (retina morphogenesis in camera-type eye), [GO:0016849](http://purl.obolibrary.org/obo/GO_0016849) (phosphorus-oxygen lyase activity), [GO:0023019](http://purl.obolibrary.org/obo/GO_0023019) (signal transduction involved in regulation of gene expression), [GO:0006366](http://purl.obolibrary.org/obo/GO_0006366) (transcription by RNA polymerase II), [GO:0001228](http://purl.obolibrary.org/obo/GO_0001228) (transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0001227](http://purl.obolibrary.org/obo/GO_0001227) (transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0021510](http://purl.obolibrary.org/obo/GO_0021510) (spinal cord development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0098535](http://purl.obolibrary.org/obo/GO_0098535) (de novo centriole assembly involved in multi-ciliated epithelial cell differentiation), [GO:0030903](http://purl.obolibrary.org/obo/GO_0030903) (notochord development), [GO:0098536](http://purl.obolibrary.org/obo/GO_0098536) (deuterosome), [GO:0030902](http://purl.obolibrary.org/obo/GO_0030902) (hindbrain development), [GO:0098534](http://purl.obolibrary.org/obo/GO_0098534) (centriole assembly), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0016175](http://purl.obolibrary.org/obo/GO_0016175) (superoxide-generating NADPH oxidase activity), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0016176](http://purl.obolibrary.org/obo/GO_0016176) (superoxide-generating NADPH oxidase activator activity), [GO:0072149](http://purl.obolibrary.org/obo/GO_0072149) (glomerular visceral epithelial cell fate commitment), [GO:0006919](http://purl.obolibrary.org/obo/GO_0006919) (activation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0010975](http://purl.obolibrary.org/obo/GO_0010975) (regulation of neuron projection development), [GO:0051209](http://purl.obolibrary.org/obo/GO_0051209) (release of sequestered calcium ion into cytosol), [GO:0032403](http://purl.obolibrary.org/obo/GO_0032403) (protein complex binding), [GO:0050910](http://purl.obolibrary.org/obo/GO_0050910) (detection of mechanical stimulus involved in sensory perception of sound), [GO:0009190](http://purl.obolibrary.org/obo/GO_0009190) (cyclic nucleotide biosynthetic process), [GO:0055129](http://purl.obolibrary.org/obo/GO_0055129) (L-proline biosynthetic process), [GO:2000553](http://purl.obolibrary.org/obo/GO_2000553) (positive regulation of T-helper 2 cell cytokine production), [GO:0060271](http://purl.obolibrary.org/obo/GO_0060271) (cilium assembly), [GO:0032088](http://purl.obolibrary.org/obo/GO_0032088) (negative regulation of NF-kappaB transcription factor activity), [GO:0005044](http://purl.obolibrary.org/obo/GO_0005044) (scavenger receptor activity), [GO:0007224](http://purl.obolibrary.org/obo/GO_0007224) (smoothened signaling pathway), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0021986](http://purl.obolibrary.org/obo/GO_0021986) (habenula development), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0021983](http://purl.obolibrary.org/obo/GO_0021983) (pituitary gland development), [GO:0043280](http://purl.obolibrary.org/obo/GO_0043280) (positive regulation of cysteine-type endopeptidase activity involved in apoptotic process), [GO:0030216](http://purl.obolibrary.org/obo/GO_0030216) (keratinocyte differentiation), [GO:2000329](http://purl.obolibrary.org/obo/GO_2000329) (negative regulation of T-helper 17 cell lineage commitment), [GO:0006801](http://purl.obolibrary.org/obo/GO_0006801) (superoxide metabolic process), [GO:0005955](http://purl.obolibrary.org/obo/GO_0005955) (calcineurin complex), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:2000321](http://purl.obolibrary.org/obo/GO_2000321) (positive regulation of T-helper 17 cell differentiation), [GO:0018344](http://purl.obolibrary.org/obo/GO_0018344) (protein geranylgeranylation), [GO:0030334](http://purl.obolibrary.org/obo/GO_0030334) (regulation of cell migration), [GO:0017137](http://purl.obolibrary.org/obo/GO_0017137) (Rab GTPase binding), [GO:0032753](http://purl.obolibrary.org/obo/GO_0032753) (positive regulation of interleukin-4 production), [GO:0032754](http://purl.obolibrary.org/obo/GO_0032754) (positive regulation of interleukin-5 production), [GO:0061034](http://purl.obolibrary.org/obo/GO_0061034) (olfactory bulb mitral cell layer development), [GO:0006461](http://purl.obolibrary.org/obo/GO_0006461) (protein complex assembly), [GO:0021978](http://purl.obolibrary.org/obo/GO_0021978) (telencephalon regionalization), [GO:0039022](http://purl.obolibrary.org/obo/GO_0039022) (pronephric duct development), [GO:0009055](http://purl.obolibrary.org/obo/GO_0009055) (electron transfer activity), [GO:0061032](http://purl.obolibrary.org/obo/GO_0061032) (visceral serous pericardium development), [GO:0016829](http://purl.obolibrary.org/obo/GO_0016829) (lyase activity), [GO:0039021](http://purl.obolibrary.org/obo/GO_0039021) (pronephric glomerulus development), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0004720](http://purl.obolibrary.org/obo/GO_0004720) (protein-lysine 6-oxidase activity), [GO:0007435](http://purl.obolibrary.org/obo/GO_0007435) (salivary gland morphogenesis), [GO:0022027](http://purl.obolibrary.org/obo/GO_0022027) (interkinetic nuclear migration), [GO:0005802](http://purl.obolibrary.org/obo/GO_0005802) (trans-Golgi network), [GO:0001568](http://purl.obolibrary.org/obo/GO_0001568) (blood vessel development), [GO:0050935](http://purl.obolibrary.org/obo/GO_0050935) (iridophore differentiation), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0032621](http://purl.obolibrary.org/obo/GO_0032621) (interleukin-18 production), [GO:0030325](http://purl.obolibrary.org/obo/GO_0030325) (adrenal gland development), [GO:0030324](http://purl.obolibrary.org/obo/GO_0030324) (lung development), [GO:0031094](http://purl.obolibrary.org/obo/GO_0031094) (platelet dense tubular network), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0005262](http://purl.obolibrary.org/obo/GO_0005262) (calcium channel activity), [GO:0006591](http://purl.obolibrary.org/obo/GO_0006591) (ornithine metabolic process), [GO:0061702](http://purl.obolibrary.org/obo/GO_0061702) (inflammasome complex), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0002674](http://purl.obolibrary.org/obo/GO_0002674) (negative regulation of acute inflammatory response), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0048505](http://purl.obolibrary.org/obo/GO_0048505) (regulation of timing of cell differentiation), [GO:0007204](http://purl.obolibrary.org/obo/GO_0007204) (positive regulation of cytosolic calcium ion concentration), [GO:0000132](http://purl.obolibrary.org/obo/GO_0000132) (establishment of mitotic spindle orientation), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0005813](http://purl.obolibrary.org/obo/GO_0005813) (centrosome), [GO:0070094](http://purl.obolibrary.org/obo/GO_0070094) (positive regulation of glucagon secretion), [GO:0032736](http://purl.obolibrary.org/obo/GO_0032736) (positive regulation of interleukin-13 production), [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole), [GO:0043066](http://purl.obolibrary.org/obo/GO_0043066) (negative regulation of apoptotic process), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0006909](http://purl.obolibrary.org/obo/GO_0006909) (phagocytosis), [GO:0070412](http://purl.obolibrary.org/obo/GO_0070412) (R-SMAD binding), [GO:0070410](http://purl.obolibrary.org/obo/GO_0070410) (co-SMAD binding), [GO:0031088](http://purl.obolibrary.org/obo/GO_0031088) (platelet dense granule membrane), [GO:0050700](http://purl.obolibrary.org/obo/GO_0050700) (CARD domain binding), [GO:0050701](http://purl.obolibrary.org/obo/GO_0050701) (interleukin-1 secretion), [GO:0032611](http://purl.obolibrary.org/obo/GO_0032611) (interleukin-1 beta production), 

**Class expressions from DL-Learner:**

- Thing 57.65%
- [GO:0098536](http://purl.obolibrary.org/obo/GO_0098536) (deuterosome) 50.35%
- [GO:0070062](http://purl.obolibrary.org/obo/GO_0070062) (extracellular exosome) 50.35%
- [GO:0031094](http://purl.obolibrary.org/obo/GO_0031094) (platelet dense tubular network) 50.35%
- [GO:0016529](http://purl.obolibrary.org/obo/GO_0016529) (sarcoplasmic reticulum) 50.35%
- [GO:0005814](http://purl.obolibrary.org/obo/GO_0005814) (centriole) 50.35%
- [GO:0005730](http://purl.obolibrary.org/obo/GO_0005730) (nucleolus) 50.35%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 50.35%
- [GO:0002102](http://purl.obolibrary.org/obo/GO_0002102) (podosome) 50.35%
- [GO:0001741](http://purl.obolibrary.org/obo/GO_0001741) (XY body) 50.35%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 39.21%
- [GO:1903561](http://purl.obolibrary.org/obo/GO_1903561) (extracellular vesicle) 35.70%
- [GO:0000803](http://purl.obolibrary.org/obo/GO_0000803) (sex chromosome) 35.70%
- [GO:0031982](http://purl.obolibrary.org/obo/GO_0031982) (vesicle) and [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 35.70%
- [GO:0043230](http://purl.obolibrary.org/obo/GO_0043230) (extracellular organelle) 29.22%


